APA (7th ed.) Citation

Suwanvecho, S., Kiatikajornthada, N., Phikulsod, P., Suwanrusme, H., & Jirawatnotai, S. Durable and Drastic Response to the Trastuzumab, Letrozole, Abemaciclib, and Goserelin Combination as First-Line Therapy in HER2-Positive and Hormone Receptor-Positive Metastatic Breast Cancer: A Case Report. Karger Publishers.

Chicago Style (17th ed.) Citation

Suwanvecho, Suthida, Narongsak Kiatikajornthada, Ployploen Phikulsod, Harit Suwanrusme, and Siwanon Jirawatnotai. Durable and Drastic Response to the Trastuzumab, Letrozole, Abemaciclib, and Goserelin Combination as First-Line Therapy in HER2-Positive and Hormone Receptor-Positive Metastatic Breast Cancer: A Case Report. Karger Publishers.

MLA (9th ed.) Citation

Suwanvecho, Suthida, et al. Durable and Drastic Response to the Trastuzumab, Letrozole, Abemaciclib, and Goserelin Combination as First-Line Therapy in HER2-Positive and Hormone Receptor-Positive Metastatic Breast Cancer: A Case Report. Karger Publishers.